Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Eystein Lønning

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Breast Care (Basel, Switzerland)|November 5, 2010
Endocrine Treatment - 'Old-Fashioned' Therapy Becoming Redundant in an Era of Molecular Medicine?Per Eystein Lønning
The Journal of Steroid Biochemistry and Molecular Biology|May 23, 2021
Letter to the EditorPer Eystein Lønning
International Journal of Clinical Oncology|August 31, 2002
The role of aromatase inactivators in the treatment of breast cancerPer Eystein Lønning
Best Practice & Research. Clinical Endocrinology & Metabolism|December 23, 2003
Oestrogen suppression--lessons from clinical studiesPer Eystein Lønning
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 19, 2005
[Aromatase inhibitors in the therapy for breast cancer]Per Eystein Lønning
Anti-Cancer Drugs|June 24, 2008
Exploring the lack of cross-resistance between aromatase inhibitors: evidence for a difference?Per Eystein Lønning
The Lancet. Oncology|December 14, 2012
Lapatinib in early breast cancer--questions to be resolvedPer Eystein Lønning
Clinical Breast Cancer|September 2, 2008
Aromatase inhibition versus placeboPer Eystein Lønning
Breast Cancer Research : BCR|January 9, 2009
Strength and weakness of phase I to IV trials, with an emphasis on translational aspectsPer Eystein Lønning
The Journal of Steroid Biochemistry and Molecular Biology|March 2, 2016
Comments on paper: "Quantitative determination of estrone by liquid chromatography-tandem mass spectrometry in subcutaneous adipose tissue from the breast in postmenopausal women" by Vihma et alPer Eystein Lønning
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Breast Care (Basel, Switzerland)|November 5, 2010
Endocrine Treatment - 'Old-Fashioned' Therapy Becoming Redundant in an Era of Molecular Medicine?Per Eystein Lønning
The Journal of Steroid Biochemistry and Molecular Biology|May 23, 2021
Letter to the EditorPer Eystein Lønning
International Journal of Clinical Oncology|August 31, 2002
The role of aromatase inactivators in the treatment of breast cancerPer Eystein Lønning
Best Practice & Research. Clinical Endocrinology & Metabolism|December 23, 2003
Oestrogen suppression--lessons from clinical studiesPer Eystein Lønning
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 19, 2005
[Aromatase inhibitors in the therapy for breast cancer]Per Eystein Lønning
Anti-Cancer Drugs|June 24, 2008
Exploring the lack of cross-resistance between aromatase inhibitors: evidence for a difference?Per Eystein Lønning
The Lancet. Oncology|December 14, 2012
Lapatinib in early breast cancer--questions to be resolvedPer Eystein Lønning
Clinical Breast Cancer|September 2, 2008
Aromatase inhibition versus placeboPer Eystein Lønning
Breast Cancer Research : BCR|January 9, 2009
Strength and weakness of phase I to IV trials, with an emphasis on translational aspectsPer Eystein Lønning
The Journal of Steroid Biochemistry and Molecular Biology|March 2, 2016
Comments on paper: "Quantitative determination of estrone by liquid chromatography-tandem mass spectrometry in subcutaneous adipose tissue from the breast in postmenopausal women" by Vihma et alPer Eystein Lønning
Pageof 14